Rituximab, Lenalidomide, and Bortezomib in the First-Line or Second-Line Treatment of Patients with Mantle Cell Lymphoma a Phase I/II Trial.
| Image |  |
|---|---|
| Description | scholarly article |
| Author/s |
author: Mark C. Mainwaring |
| Publication date | November 16, 2012 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Access work | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |